HEALTH

NSF International develops online resource for supplements information

BY Michael Johnsen

ANN ARBOR, Mich. NSF International on Tuesday launched a new online resource, http://www.nsfsport.com, to provide information to help consumers, athletes and coaches choose safer, quality supplement products.

“We are pleased to see more user-friendly resources being placed in the hands of the public,” stated Liliana Begg, manager, Clean Sport Initiative. “The Clean Sport Initiative, which provides a forum for discussions on accidental doping will now have the support of value-added informational sites that provide consumers with the guidance they need when choosing nutritional supplements.”

NSF’s Athletic Banned Substances Certification Program certifies sports supplements that have met NSF’s certification guidelines and provides key preventive measures to protect against adulteration of products, verify label claims with product contents, as well as identify any banned substances in the finished product. The certification program has been recommended by key athletic organizations, including Major League Baseball, the Major League Baseball Players Association, the National Football League, the Professional Golf Association, the National Football League Players Association and the Canadian Centre for Ethics in Sports.

Additional information, such as recent news stories on doping in sports and educational resources, can also be found at http://www.nsfsport.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Bausch & Lomb appoints new VP and global president, vision care

BY Michael Johnsen

ROCHESTER, N.Y. Bausch & Lomb on Monday named Peter Valenti corporate VP and global president, vision care, effective July 1.

Valenti replaces Stuart Heap, who has chosen to step down from his current role with B&L for personal reasons, effective June 30. Heap will remain an active strategic advisor to the company.

“[Valenti] possesses a mix of deep leadership experience, healthcare and eye health expertise, and has already made significant contributions to helping grow the B&L business during his brief tenure,” stated Gerald Ostrov, B&L chairman and CEO. “At the same time, we thank [Heap] for his significant contributions to the company as he chooses to spend more time with his family.”

Valenti joined B&L in January 2009 as president, North America, vision care. Before being named to that role, Valenti served as VP and GM, surgical devices (U.S.), for Covidien, where he led the U.S. sales and marketing strategy for the $1 billion product portfolio from 2007 to 2008.

In conjunction with Valenti’s transition to his new role, the company has named Steven Robins as president, North America, vision care.

Robins joins B&L with approximately two decades of consumer healthcare experience at leading companies such as Johnson & Johnson, Pfizer and Warner Lambert. Most recently, he was GM, Johnson & Johnson Consumer Healthcare Canada, and a VP of the Johnson & Johnson Consumer Group, with responsibility for a number of health and beauty brands such as Listerine, Reach, Band-Aid, Stayfree and Purell.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Herb works as anti-ulcer therapy, study shows

BY Michael Johnsen

BEIJING A research team led by Syed Rafatullah from Saudi Arabia validated the gastric anti-ulcer properties of the herb Rocket “Eruca sativa L.” (EER) on experimentally-induced gastric secretion and ulceration in albino rats. The study was published April 28 in the World Journal of Gastroenterology.

In recent years, Rocket “Eruca sativa L.” (EER), a member of the Brassicacae family, has gained greater importance as a salad vegetable and spice, especially among Middle Eastern populations and Europeans. It is believed that plants belonging to the Brassicacae family possess diversified medicinal and therapeutic properties including inhibition of tumorigenesis, anti-ulcer and hepatoprotective activities.

Although the introduction of proton-pump inhibitors to the classic anti-ulcer therapy has revolutionized treatment of peptic ulcers and other gastrointestinal disorders, there is still no complete cure for this disease, researchers noted. It has been shown that long term use of these drugs leads to various adverse and side effects. Relapses of the malady, ineffectiveness of different drug regimens and even resistance to drugs are emerging. Thus, there is an urgent requirement to identify more effective and safe anti-ulcer agents.

Researchers found that the ethanolic extract of EER significantly and dose-dependently reduced basal gastric acid secretion, titratable acidity and ruminal ulceration in lab rats. The authors concluded that EER extract possesses anti-ulcer activities against experimentally-induced gastric lesions.

KelloggsDRSNhttp://www.centerstoregrowth.com

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?